- Home
- RGLS vs XHG Comparison
RGLS vs XHG Comparison
Compare RGLS & XHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- XHG
- Stock Information
- Founded
- RGLS 2007
- XHG 2012
- Country
- RGLS United States
- XHG China
- Employees
- RGLS N/A
- XHG N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- XHG
- Sector
- RGLS Health Care
- XHG
- Exchange
- RGLS Nasdaq
- XHG NYSE
- Market Cap
- RGLS 102.1M
- XHG 15.0M
- IPO Year
- RGLS 2012
- XHG 2019
- Fundamental
- Price
- RGLS $1.23
- XHG $1.02
- Analyst Decision
- RGLS Strong Buy
- XHG
- Analyst Count
- RGLS 6
- XHG 0
- Target Price
- RGLS $10.33
- XHG N/A
- AVG Volume (30 Days)
- RGLS 281.3K
- XHG 10.8M
- Earning Date
- RGLS 11-07-2024
- XHG 01-24-2025
- Dividend Yield
- RGLS N/A
- XHG N/A
- EPS Growth
- RGLS N/A
- XHG N/A
- EPS
- RGLS N/A
- XHG 210.47
- Revenue
- RGLS N/A
- XHG $10,628,627.00
- Revenue This Year
- RGLS N/A
- XHG N/A
- Revenue Next Year
- RGLS N/A
- XHG N/A
- P/E Ratio
- RGLS N/A
- XHG $0.15
- Revenue Growth
- RGLS N/A
- XHG N/A
- 52 Week Low
- RGLS $1.08
- XHG $0.64
- 52 Week High
- RGLS $3.79
- XHG $60.00
- Technical
- Relative Strength Index (RSI)
- RGLS 30.55
- XHG 42.63
- Support Level
- RGLS $1.49
- XHG $0.75
- Resistance Level
- RGLS $1.64
- XHG $3.08
- Average True Range (ATR)
- RGLS 0.11
- XHG 0.38
- MACD
- RGLS -0.04
- XHG 0.08
- Stochastic Oscillator
- RGLS 11.68
- XHG 11.44
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About XHG XCHANGE TEC.INC SPON ADS EACH REP 600000 SHS(POST SPLIT)
XChange Tec Inc, through its subsidiaries operates in insurance agency and insurance technology business. Its insurance products include industry and/or state-owned property and casualty insurance and regional property and casualty insurance. The insurance technology business is focused on operating and developing insurance technology in the PRC, including developing SaaS platform to connect consumers and underwriting support.